Latest Breaking News On - Immuneering appoints rimma steinhertz - Page 1 : comparemela.com

03.01.2022 - CAMBRIDGE, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) - Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a robust pipeline of oncology and neuroscience product candidates that are designed to uniquely disrupt cellular . Seite 1

United kingdomBen zeskindRimma steinhertzAlliance managementPortfolio program managementJohnson pharmaceutical research developmentEisai incImmuneering corporation nasdaqGlenmark pharmaceuticals ichnos sciences incProgram alliance managementOncology at merck co incGlobal program leaderImmuneering appoints rimma steinhertzVice presidentChief executive officerIchnos sciences